|
Volumn 431, Issue 1, 2001, Pages 119-125
|
The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: Comparison with the sulfonylureas and nateglinide
|
Author keywords
Insulin secretion; KATP channel; Mitiglinide; Nateglinide; Sulfonylurea receptor (SUR)
|
Indexed keywords
ADENOSINE TRIPHOSPHATE;
ANTIDIABETIC AGENT;
GLIBENCLAMIDE;
GLUCOSE;
MEGLITINIDE;
MITIGLINIDE;
NATEGLINIDE;
POTASSIUM CHANNEL;
POTASSIUM CHANNEL BLOCKING AGENT;
REPAGLINIDE;
SULFONYLUREA DERIVATIVE;
TOLBUTAMIDE;
TRITIUM;
ANIMAL CELL;
ARTICLE;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG BINDING;
DRUG BINDING SITE;
DRUG EFFECT;
DRUG SELECTIVITY;
DRUG SPECIFICITY;
INSULIN RELEASE;
INSULIN RESPONSE;
NONHUMAN;
PANCREAS ISLET BETA CELL;
PATCH CLAMP;
POTASSIUM CURRENT;
PRIORITY JOURNAL;
ANIMALS;
ATP-BINDING CASSETTE TRANSPORTERS;
CELL LINE;
COS CELLS;
CYCLOHEXANES;
GLYBURIDE;
HYPOGLYCEMIC AGENTS;
INDOLES;
INSULIN;
PATCH-CLAMP TECHNIQUES;
PHENYLALANINE;
POTASSIUM CHANNELS;
POTASSIUM CHANNELS, INWARDLY RECTIFYING;
RECEPTORS, DRUG;
SULFONYLUREA COMPOUNDS;
TOLBUTAMIDE;
TRANSFECTION;
|
EID: 0035834523
PISSN: 00142999
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-2999(01)01412-1 Document Type: Article |
Times cited : (73)
|
References (34)
|